Autoimmune Uveitis: Causes, Symptoms, Diagnosis, Treatment, and Long-Term Management
Description: Learn everything about autoimmune uveitis, including its causes, symptoms, associated autoimmune diseases, diagnosis, treatment options, complications, and prevention.
Primary Keyword: Autoimmune uveitis
Secondary Keywords: autoimmune eye disease, autoimmune uveitis symptoms, autoimmune uveitis treatment, non-infectious uveitis, anterior uveitis autoimmune, inflammatory eye disease
Autoimmune uveitis is a non-infectious inflammatory disease in which the body's immune system mistakenly attacks healthy tissues inside the eye. Instead of protecting the body from harmful bacteria and viruses, the immune system targets the uvea—the eye's middle vascular layer—causing inflammation that can damage vision.
Autoimmune uveitis may occur as an isolated eye condition or as part of a systemic autoimmune disease such as ankylosing spondylitis, Behçet disease, sarcoidosis, juvenile idiopathic arthritis, or inflammatory bowel disease.
If left untreated, autoimmune uveitis can lead to cataracts, glaucoma, macular oedema, retinal damage, and permanent vision loss. Fortunately, modern immunosuppressive therapies and biologic medications have greatly improved long-term outcomes.
Table of Contents
- What is autoimmune uveitis?
- How the immune system causes uveitis
- Which autoimmune diseases are associated?
- Types of autoimmune uveitis
- Symptoms
- Risk factors
- Diagnosis
- Treatment
- Biologic therapy
- Complications
- Long-term management
- Prevention
- Frequently Asked Questions
What Is Autoimmune Uveitis?
Autoimmune uveitis is inflammation of the uvea caused by an abnormal immune response, rather than by bacteria, viruses, fungi, or parasites.
The immune system normally recognises and destroys harmful microorganisms. In autoimmune diseases, however, immune cells mistakenly attack the body's own tissues. When this attack is directed at the eye, inflammation develops in the iris, ciliary body, choroid, retina, or surrounding structures.
Because the eye is highly sensitive, even mild inflammation can interfere with vision.
Understanding the Uvea
The uvea consists of three parts:
Iris
The coloured part of the eye that controls the amount of light entering through the pupil.
Ciliary Body
Produces aqueous humour and changes the shape of the lens for focusing.
Choroid
A highly vascular layer that supplies oxygen and nutrients to the retina.
Inflammation affecting any of these structures is known as uveitis.
How Does Autoimmune Uveitis Develop?
Normally, the immune system distinguishes between the body's own tissues and foreign organisms. In autoimmune uveitis, this recognition process fails.
The inflammatory process involves:
- Activation of T lymphocytes
- Release of inflammatory cytokines
- Breakdown of the blood–ocular barrier
- Entry of immune cells into the eye
- Persistent inflammation of ocular tissues
This ongoing inflammation can damage the retina, optic nerve, and other structures if not controlled.
Autoimmune Diseases Associated with Uveitis
Several autoimmune and inflammatory disorders increase the risk of developing uveitis.
1. Ankylosing Spondylitis
One of the most common causes of recurrent anterior uveitis.
Features include:
- Lower back pain
- Morning stiffness
- HLA-B27 positivity
- Recurrent painful red eye
2. Behçet Disease
Behçet disease is a multisystem inflammatory disorder that commonly affects:
- Eyes
- Mouth
- Skin
- Genitals
- Blood vessels
It often causes severe recurrent panuveitis and retinal vasculitis.
3. Sarcoidosis
Sarcoidosis is characterised by granuloma formation in multiple organs.
Commonly affected organs include:
- Lungs
- Lymph nodes
- Skin
- Eyes
Patients may develop chronic anterior, intermediate, or posterior uveitis.
4. Juvenile Idiopathic Arthritis (JIA)
Children with JIA are at risk of chronic anterior uveitis.
Unlike adults, children may have little or no eye pain, making regular screening essential.
5. Psoriatic Arthritis
Inflammation associated with psoriasis can involve the eyes, causing recurrent anterior uveitis.
6. Inflammatory Bowel Disease
Both Crohn's disease and ulcerative colitis are linked with episodes of autoimmune uveitis.
7. Systemic Lupus Erythematosus (SLE)
Lupus can affect the retina, choroid, and other ocular tissues through immune-mediated inflammation.
Types of Autoimmune Uveitis
Depending on the location of inflammation, autoimmune uveitis may be classified as:
- Anterior uveitis – affects the iris and ciliary body.
- Intermediate uveitis – involves the vitreous and pars plana.
- Posterior uveitis – affects the retina and choroid.
- Panuveitis – involves all parts of the uveal tract.
The pattern often provides clues to the underlying autoimmune disease.
Symptoms of Autoimmune Uveitis
Symptoms may develop suddenly or gradually and include:
- Eye redness
- Eye pain
- Blurred vision
- Floaters
- Sensitivity to light (photophobia)
- Decreased vision
- Excessive tearing
- Headache around the eye
- Small or irregular pupil (in anterior uveitis)
Chronic inflammation may produce few symptoms initially, making regular eye examinations important for high-risk individuals.
Risk Factors
Factors that increase the likelihood of autoimmune uveitis include:
- HLA-B27 positivity
- Existing autoimmune disease
- Family history of autoimmune disorders
- Previous episodes of uveitis
- Smoking
- Young and middle adulthood
- Female sex in certain autoimmune diseases
How Is Autoimmune Uveitis Diagnosed?
Diagnosis involves identifying both the eye inflammation and any associated systemic disease.
Eye Examination
Your ophthalmologist may perform:
- Visual acuity testing
- Slit-lamp examination
- Intraocular pressure measurement
- Dilated retinal examination
Imaging Tests
Advanced imaging may include:
- Optical Coherence Tomography (OCT)
- OCT Angiography (OCTA)
- Fundus photography
- Fluorescein angiography
- B-scan ultrasonography
Laboratory Investigations
Depending on your symptoms, your doctor may request:
- Complete blood count
- ESR and CRP
- HLA-B27 testing
- Antinuclear antibody (ANA)
- Rheumatoid factor (RF)
- Anti-CCP antibodies
- ACE levels (for sarcoidosis)
- Tuberculosis screening
- Syphilis serology
- Chest X-ray or CT scan
In some cases, collaboration with a rheumatologist or immunologist is required.
Treatment of Autoimmune Uveitis
The goals of treatment are to:
- Reduce inflammation
- Prevent permanent eye damage
- Preserve vision
- Treat the underlying autoimmune disease
- Reduce the risk of recurrence
Corticosteroid Eye Drops
First-line treatment for mild anterior uveitis.
Oral Corticosteroids
Used for moderate to severe inflammation or when the back of the eye is involved.
Periocular or Intravitreal Steroid Injections
Provide targeted treatment for intermediate or posterior uveitis.
Immunosuppressive Medications
Long-term steroid use can cause significant side effects, so steroid-sparing drugs are often prescribed.
Common medications include:
- Methotrexate
- Azathioprine
- Mycophenolate mofetil
- Cyclosporine
- Tacrolimus
Biologic Therapy
Patients with severe or recurrent autoimmune uveitis may benefit from biologic medications.
Common biologic agents include:
- Adalimumab
- Infliximab
- Tocilizumab (selected cases)
- Rituximab (certain autoimmune conditions)
These drugs target specific inflammatory pathways and are often prescribed when conventional immunosuppressive therapy is insufficient.
Possible Complications
Without prompt treatment, autoimmune uveitis may cause:
- Cataract
- Secondary glaucoma
- Macular oedema
- Posterior synechiae
- Retinal vasculitis
- Retinal detachment
- Optic nerve damage
- Permanent vision loss
Early treatment and regular monitoring greatly reduce these risks.
Living with Autoimmune Uveitis
Because autoimmune uveitis can recur, long-term management is essential.
Patients should:
- Attend regular eye examinations.
- Take medications exactly as prescribed.
- Report new symptoms immediately.
- Keep autoimmune diseases well controlled.
- Avoid smoking.
- Maintain regular follow-up with both an ophthalmologist and a rheumatologist when appropriate.
Can Autoimmune Uveitis Be Prevented?
There is no guaranteed way to prevent autoimmune uveitis, but the risk of flare-ups may be reduced by:
- Controlling underlying autoimmune diseases.
- Taking immunosuppressive medications as prescribed.
- Avoiding smoking.
- Keeping scheduled follow-up appointments.
- Seeking prompt medical care for new eye symptoms.
Frequently Asked Questions
Is autoimmune uveitis contagious?
No. Autoimmune uveitis is caused by an abnormal immune response and cannot spread from one person to another.
Can autoimmune uveitis recur?
Yes. Many patients experience recurrent episodes, particularly if the underlying autoimmune disease remains active.
Is autoimmune uveitis curable?
While there may not be a permanent cure, many patients achieve long-term remission with appropriate treatment and monitoring.
Which autoimmune disease most commonly causes uveitis?
Ankylosing spondylitis and other HLA-B27-associated disorders are among the most common causes of autoimmune anterior uveitis.
Can autoimmune uveitis cause blindness?
Yes. Untreated or severe inflammation can lead to irreversible vision loss through complications such as glaucoma, cataract, macular oedema, and retinal damage.
Key Takeaways
- Autoimmune uveitis is a non-infectious inflammatory eye disease caused by the immune system attacking healthy ocular tissues.
- It is frequently associated with systemic conditions such as ankylosing spondylitis, Behçet disease, sarcoidosis, juvenile idiopathic arthritis, inflammatory bowel disease, and lupus.
- Common symptoms include eye pain, redness, blurred vision, floaters, and sensitivity to light.
- Diagnosis requires a comprehensive eye examination, ocular imaging, and laboratory testing to identify underlying autoimmune disorders.
- Treatment often includes corticosteroids, immunosuppressive medications, and biologic therapies to control inflammation and preserve vision.
- Early diagnosis, consistent follow-up, and multidisciplinary care are essential for preventing complications and maintaining long-term eye health.
Keywords:
By TheFutureMed Editorial Team
Status: Published